Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization [...]
Need a new search
If you didn't find what you were looking for, try a new search!
Relievant announces publication of 5-Year data demonstrating long-term clinical benefits of the Intracept procedure in chronic low back pain patients
Relievant announces publication of 5-Year data demonstrating long-term clinical [...]
Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain
Relievant Announces Publication of Positive Results from Multi-Center Study [...]
Interview with Kevin Hykes, President & CEO at Relievant
Interview with Kevin Hykes, President & CEO at Relievant [...]
Relievant announces publication of SMART trial 24-month results
Relievant announces publication of SMART trial 24-month results [...]
Relievant announces Level 1 INTRACEPT study stopped early for superiority
Relievant announces Level 1 INTRACEPT study stopped early for [...]
Relievant announces reimbursement codes and APC assignment for the Intracept Procedure
Relievant announces reimbursement codes and APC assignment for the [...]
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Relievant Announces Completion of $58M Series E Financing to [...]
Vertiflex Announces Appointments to Board of Directors, Ray Baker, MD, and Richard Mott
Vertiflex Announces Appointments to Board of Directors, Ray Baker, [...]